Cargando…

Buttressing regulation of cognitive enhancement devices with principles of harm reduction

Maslen and colleagues offer an excellent model for regulating cognitive enhancement devices (CEDs), and we largely endorse their approach of extending medical device policy to include CEDs. Maslen et al. argue that since the risks and benefits of CEDs can be identified, consumers are best placed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fitz, Nicholas S., Reiner, Peter B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Peer Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5033527/ https://www.ncbi.nlm.nih.gov/pubmed/27774171 http://dx.doi.org/10.1093/jlb/lsu018

Ejemplares similares

Regulation of cognitive enhancement devices: commentary
por: Johnson, Reuben, et al.
Publicado: (2014)

The brain, cognitive enhancement devices, and European regulation
por: Kuersten, Andreas, et al.
Publicado: (2014)

Medical regulation of cognitive enhancement devices: some concerns
por: King, Mike, et al.
Publicado: (2014)

Outstanding questions concerning the regulation of cognitive enhancement devices
por: De Ridder, Dirk, et al.
Publicado: (2014)

FDA's pathway for regulation of FMT: not so fraught
por: Riley, Margaret F., et al.
Publicado: (2015)

Precision medicine: a matter of regulation or collaboration?
por: Knoppers, Bartha Maria
Publicado: (2016)

Two kinds of rule regulating human subjects research
por: Sachs, Benjamin
Publicado: (2015)

Modernizing biomedical regulation: foresight and values in the promotion of responsible research and innovation
por: Harmon, Shawn H.E.
Publicado: (2016)

Regulating drug promotion to promote the public health: a response to Bennett et al.
por: Zettler, Patricia J.
Publicado: (2015)

What do experimental simulations tell us about the effect of neuro/genetic evidence on jurors?
por: Scurich, Nicholas
Publicado: (2018)

Yesterday's war; tomorrow's technology: peer commentary on ‘Ethical, legal, social and policy issues in the use of genomic technologies by the US military’
por: Evans, Nicholas G., et al.
Publicado: (2014)

Neuroscience cannot answer these questions: a response to G. and R. Murrow's essay hypothesizing a link between dehumanization, human rights abuses and public policy
por: Hoffman, Morris B.
Publicado: (2015)

Hate speech, volition, and neurology
por: Roginsky, Alexandra B., et al.
Publicado: (2015)

Law and neuroscience: recommendations submitted to the President's Bioethics Commission
por: Jones, Owen D., et al.
Publicado: (2014)

The Olympics and harm reduction?
por: Kayser, Bengt, et al.
Publicado: (2012)

Harm reduction in hospitals
por: Sharma, Malika, et al.
Publicado: (2017)

Props and Buttresses
Publicado: (1890)

Environmental neuroethics: changing the environment—changing the brain Recommendations submitted to the Presidential Commission for the Study of Bioethical Issues
por: Illes, Judy, et al.
Publicado: (2014)

Letter
Publicado: (2014)

Ethical considerations of neuroscience research and the application of neuroscience research findings for the Presidential Commission for the Study of Bioethical Issues
Publicado: (2014)

Considering advances in neuroscience through the lenses of law and human rights
por: Frankel, Mark S.
Publicado: (2014)

Military genomic testing: proportionality, expected benefits, and the connection between genotypes and phenotypes
por: Pence, Charles H.
Publicado: (2014)

Science wars—How much risk should soldiers be exposed to in military experimentation?
por: Savulescu, Julian
Publicado: (2015)

Dehumanization: its operations and its origins
por: Simpson, Robert Mark
Publicado: (2015)

Orphan drug incentives in the pharmacogenomic context: policy responses in the USA and Canada
por: Herder, Matthew
Publicado: (2016)

Egg freezing, stratified reproduction and the logic of not
por: Ikemoto, Lisa C.
Publicado: (2015)

‘Good soldiers are made, not born’(⊥): the dangers of medicalizing ability in the military use of genetics
por: Roberts, Jessica L.
Publicado: (2015)

The most plausible pro-coercion view: requiring informed agreement while penalizing non-participation in research
por: Barnhill, Anne
Publicado: (2015)

Informed consent to participation in interventional studies: second-order in a different sense
por: Eyal, Nir
Publicado: (2015)

Are ethics promulgations self-defeating?
por: Gray, Derrick
Publicado: (2015)

Diversion effects, incentive effects, and the goals of research ethics promulgations
por: Wenner, Danielle M.
Publicado: (2015)

Commentary: Is there a problem Consent in Escrow can solve?
por: Taylor, Holly A.
Publicado: (2015)

The problems of liminal states, line drawing, and false dichotomies
por: Suter, Sonia
Publicado: (2015)

The patent law Duchy of Grand Fenwick: a comment on The mouse that trolled: the long and tortuous history of a gene mutation patent that became an expensive impediment to Alzheimer's research
por: Sarnoff, Joshua D.
Publicado: (2015)

Off-label drug promotion and the ephemeral line between marketing and education
por: Krause, Joan H.
Publicado: (2015)

The mouse that trolled
por: Hardy, John
Publicado: (2015)

Universities and Patent Demands
por: Cordova, Andrew K., et al.
Publicado: (2015)

It depends whose data are being shared: considerations for genomic data sharing policies
por: Robinson, Jill O., et al.
Publicado: (2015)

A problem not yet manifest: gaps in insurance coverage of medical interventions after genetic testing
por: Malanga, Sarah, et al.
Publicado: (2015)

Comment on mitochondrial replacement techniques and the birth of the ‘first’
por: Dimond, Rebecca, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nhhgmhtk60h0cevobpkg6rls8j